Intermittent subcutaneous opioids for the management of cancer pain

Journal of Palliative Medicine

Volumn 11, Issue 10, 2008, Pages 1319-1324

  Parsons, Henrique A ^a   Shukkoor, Abdul ^b   Quan, Hue ^c   Delgado Guay, Marvin O ^a   Palmer, J Lynn ^a   Fainsinger, Robin ^b,c   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Capital Health Edmonton   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE;

ADULT; AGED; ANALGESIA; ARTICLE; CANCER PAIN; CANCER PATIENT; CONTROLLED STUDY; DRUG COST; DRUG DOSE TITRATION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; FEMALE; HEALTH CARE COSTS; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PAIN MEASUREMENT; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 58149267982     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2008.0155     Document Type: Article

References (30)

1. Goudas LC, Bloch R, Gialeli-Goudas M, Lau J, Carr DB: The epidemiology of cancer pain. Cancer Invest 2005;2:182-190.
2. World Health Organization: Cancer Pain Relief. Geneva: World Health Organization, 1986.
3. Ripamonti C, Bruera E: Rectal, buccal, and sublingual narcotics for the management of cancer pain. J Palliat Care 1991;1:30-35.
4. Nelson KA, Glare PA, Walsh D, Groh ES: A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain. J Pain Symptom Manage 1997;5:262-267.
5. Bruera E, Brenneis C, MacDonald RN: Continuous Sc infusion of narcotics for the treatment of cancer pain: An update. Cancer Treat Rep 1987;10:953-958.
6. Bruera E, Brenneis C, Michaud M, Bacovsky R, Chadwick S, Emeno A, MacDonald N: Use of the subcutaneous route for the administration of narcotics in patients with cancer pain. Cancer 1988;2:407-411.
7. Crane RA: Intermittent subcutaneous infusion of opioids in hospice home care: An effective, economical, manageable option. Am J Hosp Palliat Care 1994;1:8-12.
8. Bruera E, Velasco-Leiva A, Spachynski K, Fainsinger R, Miller MJ, MacEachern T: Use of the Edmonton Injector for parenteral opioid management of cancer pain: A study of 100 consecutive patients. J Pain Symptom Manage 1993; 8:525-528.
9. Gagnon B, Bielech M, Watanabe S, Walker P, Hanson J, Bruera E: The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain. Support Care Cancer 1999;4:265-270.
10. Letizia M, Shenk J, Jones TD: Intermittent subcutaneous injections of pain medication: Effectiveness, manageability, and satisfaction. Am J Hosp Palliat Care 1999;4:585-592.
11. Bruera E, MacMillan K, Hanson J, MacDonald RN: The Edmonton injector: A simple device for patient-controlled subcutaneous analgesia. Pain 1991;2:167-169.
12. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K: The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. J Palliat Care 1991;2:6-9.
13. Chang VT, Hwang SS, Feuerman M: Validation of the Edmonton Symptom Assessment Scale. Cancer 2000;9: 2164-2171.
14. Nekolaichuk C, Watanabe S, Beaumont C: The Edmonton Symptom Assessment System: A 15-year retrospective review of validation studies (1991-2006). Palliat Med 2008;2:111-122.
15. MacMillan K, Perry B, MacKay SA, Bruera E: Your patient has an Edmonton injector - Information for the Health Care Professional regarding use of the Edmonton Injector. Alberta Cancer Board/Cross Cancer Institute 1993.
16. Regional Palliative Care Program: Clinical Practice Guidelines - Edmonton Injector Protocol for Intermittent Subcutaneous Injections. www.palliative.org/PC/ClinicalInfo/ Clinical%20Practice%20Guidelines/ PDF%20files/ Edmonton% 20Injector%20for%20Intermittent%20Subcutaneous% 20Injection.pdf (Last accessed April 25, 2008).
17. Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E: Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. J Pain Symptom Manage 2001;2:672-687.
18. Lawlor P, Pereira J, Bruera E: Dose Ratios Among Different Opioids: Underlying issues and an update on the use of the equianalgesic table. In: Bruera E, Portenoy RK (eds): Topics in Palliative Care, 5. New York: Oxford University Press, 2001, pp. 247-276
19. Regional Palliative Care Program: Annual Report 2004-2006 Grey Nuns Community Hospital 2007. www.palliative.org/ PC/RPCP/RPCPIdx.html (Last accessed April 25, 2008).
20. Brenneis C, Michaud M, Bruera E, MacDonald RN: Local toxicity during the subcutaneous infusion of narcotics (SCIN). A prospective study. Cancer Nurs 1987;4:172-176.
21. Bruera E, Brenneis C, Michaud M, MacMillan K, Hanson J, MacDonald RN: Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain. J Natl Cancer Inst 1988;14: 1152-1154.
22. Bruera E, MacEachern T, Macmillan K, Miller MJ, Hanson J: Local tolerance to subcutaneous infusions of high concentrations of hydromorphone: A prospective study. J Pain Symptom Manage 1993;4:201-204.
23. Moulin DE, Kreeft JH, Murray-Parsons N, Bouquillon AI: Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet 1991;8739:465-468.
24. Fudin J, Smith HS, Toledo-Binette CS, Kenney E, Yu AB, Boutin R: Use of continuous ambulatory infusions of concentrated subcutaneous (s.q.) hydromorphone versus intravenous (i.v.) morphine: Cost implications for palliative care. Am J Hosp Palliat Care 2000;5:347-353.
25. Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Almazor ME, Bruera ED: Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study. Arch Intern Med 2000;6:786-794.
26. Stromgren AS, Sjogren P, Goldschmidt D, Petersen MA, Pedersen L, Groenvold M: Symptom priority and course of symptomatology in specialized palliative care. J Pain Symptom Manage 2006;3:199-206.
27. Watanabe S, Pereira J, Tarumi Y, Hanson J, Bruera E: A randomized double-blinded crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain. J Palliat Med 2008;4:570-574.
28. Anderson SL, Shreve ST: Continuous subcutaneous infusion of opiates at end-of-life. Ann Pharmacother 2004;6:1015-1023.
29. Koshy RC, Kuriakose R, Sebastian P, Koshy C: Continuous morphine infusions for cancer pain in resource-scarce environments: Comparison of the subcutaneous and intravenous routes of administration. J Pain Palliat Care Pharmacother 2005;1:27-33.
30. De Lima L, Sweeney C, Palmer JL, Bruera E: Potent analgesics are more expensive for patients in developing countries: A comparative study. J Pain Palliat Care Pharmacother 2004;1:59-70.